Author:
Garcia Analia E.,Rico Mario C.,Liverani Elisabetta,DeLa Cadena Raul A.,Bray Paul F.,Kunapuli Satya P.
Publisher
Public Library of Science (PLoS)
Reference37 articles.
1. Review of prasugrel for the secondary prevention of atherothrombosis;SA Spinler;J Manag Care Pharm,2009
2. Interaction of the active metabolite of prasugrel, R-138727, with cysteine 97 and cysteine 175 of the human P2Y12 receptor;I Algaier;J Thromb Haemost,2008
3. Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity;Y Niitsu;Semin Thromb Hemost,2005
4. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity;PA Gurbel;Circulation,2003
5. Prasugrel overcomes high on-clopidogrel platelet reactivity post-stenting more effectively than high-dose (150-mg) clopidogrel: the importance of CYP2C19*2 genotyping;D Alexopoulos;JACC Cardiovasc Interv,2011
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献